News and Trends 25 Nov 2024
Evotec on the brink of acquisition: At what cost for the biotech industry?
As the signs point toward a potential Evotec acquisition, delve into what it could represent for the European biotech landscape.
News and Trends
- Latest Posts
News and Trends 4 Nov 2024
Top biotech deals of October 2024
Discover the major biotech partnerships, collaborations and mergers and acquisitions that made headlines in October 2024.
News and Trends 31 Oct 2024
Halloween biotech stories: Unveiling scientists’ worst fears
What are scientists scared of? Delve into three biotech sci-fi-inspired scenarios that might make you fear progress.
News and Trends 24 Oct 2024
Fighting severe epilepsies: A new era for Dravet syndrome treatment?
Delve into the field of severe epilepsies as new treatments for Dravet syndrome are progressing through the pipeline.
News and Trends 23 Oct 2024
RNA editing in humans: the race begins with first successful trial
Wave Life Sciences achieves RNA editing in the clinic, crossing a major milestone in the space.
News and Trends 21 Oct 2024
Turning back time with cellular reprogramming: Shift raises $16 million in seed funding
As Shift Bioscience raises $16 million in seed funding, delve into the field of cellular reprogramming to tackle age-related diseases.
ADVERTISEMENT
ADVERTISEMENT
News and Trends 15 Oct 2024
Booster launches to treat neurodegenerative diseases with proteasome activation
Discover Booster Therapeutics’ novel proteasome activation approach to neurodegenerative diseases as it launches with $15 million.
News and Trends 10 Oct 2024
Second biotech IPO boom of the year: what does it mean for the industry?
Discover why biotech is experiencing a second IPO boom in 2024 and what it means for the broader industry.
News and Trends 3 Oct 2024
Resolution Therapeutics raises $85 million to advance its macrophage therapy
Find out about Resolution Therapeutics’ macrophage therapy, as it just raised $85 million in a series B round.
News and Trends 2 Oct 2024
Niemann-Pick disease: FDA approves first two drugs in the space of a week for rare disorder
Find out all about the first two FDA drug approvals for the rare genetic disorder Niemann-Pick disease type C.
News and Trends 30 Sep 2024
The race for a bird flu vaccine: milestones and breakthroughs
The recent uptick in U.S. bird flu cases poses a threat to public health. Biotechs are now developing vaccines to mitigate the outbreak.
News and Trends 27 Sep 2024
Aptadir Therapeutics launches to develop new class of RNA inhibitors against cancer and genetic disorders
Italian startup Aptadir Therapeutics has launched with $1.6 million to bring a new class of drugs to the clinic and a technology to be reckoned with.
ADVERTISEMENT
